cefuroxime has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rudnicka, L | 1 |
Szymańska, E | 1 |
Walecka, I | 1 |
Słowińska, M | 1 |
1 other study available for cefuroxime and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.
Topics: Adult; Cefuroxime; Cephalosporins; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Skin | 2000 |